Deborah Gold, Chief Executive said:
Deborah Gold, Chief Executive of National AIDS Trust, said:
“Long-acting injectables have been proven to be a safe and effective method of delivering HIV treatment, so we are delighted that NICE has approved the use of cabotegravir with rilpivirine for adults living with HIV.
Deborah Gold, Chief Executive of National AIDS Trust, said:
"The Government was silent today on funding for HIV and ominous on public health.
"If it is serious about ‘combating health disparities’ it must fulfil its commitment to end new cases of HIV by 2030 by funding an ambitious HIV Action Plan by 1 December this year.
"The end of the HIV epidemic in England is possible, and it’s affordable. But it won’t happen without radical action. The focus is now on Sajid Javid and the Department of Health and Social Care to invest early and keep their promises on #0HIVby30. The clock is ticking."
Deborah Gold, Chief Executive of National AIDS Trust, said:
“I applaud Charity Kase’s decision to be open about HIV. Better awareness about the reality of HIV today is vital to tackling stigma surrounding HIV and the information Charity has shared on RuPaul’s Drag Race UK tonight will educate so many.
Deborah Gold, Chief Executive of National AIDS Trust, said:
“We are delighted to see the Scottish Medicines Consortium has laid the groundwork for long-acting injectables by approving the use of cabotegravir with rilpivirine for adults living with HIV in Scotland.
“Clinical trials have already shown that this method of delivering treatment is safe and effective, and people living with HIV are highly satisfied with monthly injections compared with daily pills.
The Joint Committee on Vaccination and Immunisation (JCVI) has updated its advice on COVID vaccination:
As a coalition of HIV and sexual health charities, we want to underscore our absolute commitment to supporting the rights of our trans, non-binary, and gender diverse communities.
There is a long history of commitment and mutual support between gender and sexual minorities facing shared struggles. Just as trans people have been central to the battle for LGBTQ equality they have been key players in the fight against HIV. We will be better equipped to meet the challenge of ending HIV by 2030 by standing together.
